Introduction
============

Nattokinase is a serin protease derived from fermentation of boiled soy bean that has a potent fibrinolytic effect \[[@B1]\]. The aim of this experimental study was to investigate the effects of nattokinase on plasma fibrinogen levels, whole blood viscosity and mortality in rats with sepsis.

Methods
=======

Fifty adult female Wistar rats were used in the study. Nattokinase (6 mg/day) was given via the intragastric route for 7 days. Sepsis was induced by cecal ligation--puncture. Analysis of plasma fibrinogen levels, whole blood viscosity and survival was performed.

Results
=======

Mean plasma fibrinogen levels of rats that received nattokinase prior to cecal ligation--puncture were lower than the others that did not receive nattokinase prior to cecal ligation--puncture and the sham-operated group, but the differences were not statistically significant. Mean blood viscosity of rats analyzed with the Rheolog™ scanning capillary viscometer was lower in the nattokinase-supplemented animals with cecal ligation--puncture group at a 1/second shear rate (*P*\< 0.05) (Figure [1](#F1){ref-type="fig"}). Nattokinase supplementation did not significantly influence survival rates and survival times of the rats after cecal ligation--puncture.

![**Comparison of mean blood viscosity data of the groups Lap (sham-operated group), CLP (cecal ligation--puncture group) and Nat + CLP (nattokinase-supplemented cecal ligation--puncture group)**.](cc7501-1){#F1}

Conclusion
==========

The results of our *in vivo*study were not sufficient to prove the fibrinogenolytic effect of nattokinase but confirmed the results of a previous *in vitro*study investigating the effect of nattokinase on blood viscosity. More *in vivo*and *in vitro*studies with large study populations are required to investigate the use of nattokinase to prevent and treat sepsis-related disseminated intravascular coagulation.
